Changes in premorbid brain volume predict Alzheimer's disease pathology

Neurology

Volumn 61, Issue 4, 2003, Pages 487-492

  Silbert, Lisa C ^a,c   Quinn, J F ^a,c   Moore, M M ^a   Corbridge, E ^a   Ball, M J ^a   Murdoch, G ^a   Sexton, G ^b   Kaye, J A ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN SIZE; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MEASUREMENT; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0042932776     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000079053.77227.14     Document Type: Article

References (27)

1. Kaye J. Methods for discerning disease-modifying effects in Alzheimer disease treatment trials. Arch Neurol 2000;57:312-314.
2. Fox N, Cousens S, Scahill R, Harvey R, Rossor M. Using serial registered brain MRI to measure disease progression in Alzheimer's disease. Arch Neurol 2000;57:339-344.
3. Morris J, Storandt M, McKeel Jr D, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-719.
4. Bobinski M, Wegiel J, Tarnawski M, et al. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer's disease. J Neuropathol Exp Neurol 1997;56:414-420.
5. Bobinski M, Leon M, Tarnawski M, et al. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res 1998;805:267-269.
6. Kanne S, Balota D, Storandt M, McKeel D, Morris J. Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurology 1998;50:979-985.
7. Schmitt F, Davis D, Wekstein D, Smith C, Ashford J, Markesbery W. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology 2000;55:370-376.
8. Huesgen C, Burger P, Crain B, Johnson G. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 1993;43:145-152.
9. Bobinski M, Leon M, Weigel J, et al. The histological validation of post mortem MRI-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000;95:721-725.
10. Jobst K, Smith A, Barker C, et al. Association of atrophy of the medial temporal lobe with reduced blood Dow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-194.
11. Jack C, Dickson D, Parisi J, et al. Antemortem MRI finds correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-757.
12. Green M, Kaye J, Ball M. The Oregon Brain Aging Study: neuropathology accompanying healthy aging in the oldest old. Neurology 2000;54:105-113.
13. McKahnn G, Drachman D. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
14. Howieson D, Holm L, Kaye J, Oken B, Howieson J. Neurologic function in the optimally healthy oldest old: neuropsychologic evaluation. Neurology 1984;34:939-944.
15. McNeal M, Zareparsi S, Camicioli R, et al. Predictors of healthy brain aging. J Gerontol A Biol Sci Med Sci 2001;56A:B294-B301.
16. Hickman S, Howieson D, Dame A, Sexton G, Kaye J. Longitudinal analysis of the effects of the aging process on neuropsychological test performance in the healthy young old and oldest old. Dev Neuropsychol 2000;17:323-337.
17. Morris J. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
18. Folstein M, Folstein S, McHugh P. "Mini-mental state"-a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;189-198.
19. Kiernan R, Meuller J, Langston J, Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but differentiated approach to cognitive assessment. Ann Intern Med 1987;107:734-739.
20. Kaye J, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304.
21. Mueller E, Moore M, Kerr D, et al. Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998;51:1555-1562.
22. Mirra S, Heyman A. CERAD guide to the neuropathological assessment of Alzheimer's disease and other dementias. Durham, NC: CERAD, 1994.
23. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer's type: a pathoanatomical study. Ann Neurol 1986;19:253-262.
24. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995;89:35-41.
25. Tomimoto H, Akiguchi I, Akiyama H, et al. Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol 1999;97:629-634.
26. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
27. Gosche K, Mortimer J, Smith C, Markesbery W, Snowdon D. Hippocampal volume as an index of Alzheimer neuropathology. Findings from the Nun Study. Neurology 2002;58:1476-1482.